Submit Your Biomarker Discovery Research
Join leading researchers advancing personalized medicine through innovative biomarker science
Complete your submission in just 15 minutes
Two Convenient Submission Methods
We offer two streamlined pathways for submitting your biomarker research. Choose the method that best fits your workflow and manuscript complexity.
ManuscriptZone Portal
Our comprehensive submission platform designed for complete manuscript management and real-time tracking throughout the peer review process.
- Auto-save functionality protects your work
- Guided step-by-step submission workflow
- Real-time status tracking and notifications
- Direct access to reviewer comments and decisions
- Secure document management system
- Revision submission and version control
Best for: Complex biomarker studies, multi-author manuscripts, and researchers who want complete visibility into the review process.
Submit via ManuscriptZoneQuick Submission Form
A streamlined, single-page submission form for straightforward manuscripts that don't require extensive tracking or multiple revisions.
- Simple one-page submission interface
- No account registration required
- Fast upload for ready manuscripts
- Ideal for time-sensitive submissions
- Email confirmation upon receipt
- Transferred to ManuscriptZone for review
Best for: Short communications, preliminary biomarker findings, and authors seeking the fastest submission path.
Use Quick Submission FormBiomarker Research We Publish
The International Journal of Personalized Medicine specializes in non-clinical biomarker research that advances our understanding of molecular signatures, validation methodologies, and stratification algorithms. We welcome submissions across all stages of biomarker development.
Original Biomarker Discovery Studies
Novel identification of molecular biomarkers using genomic, proteomic, metabolomic, or multi-omics approaches. Include validation cohorts and statistical methodologies.
Biomarker Validation Studies
Independent validation of previously identified biomarkers in new cohorts. Focus on reproducibility, analytical validation, and performance metrics (sensitivity, specificity, AUC).
Algorithm Development & Machine Learning
Computational models for biomarker-based patient stratification, risk prediction, or molecular classification. Include training/validation datasets and performance benchmarks.
Systematic Reviews & Meta-Analyses
Comprehensive synthesis of biomarker literature following PRISMA guidelines. Focus on biomarker performance across studies, heterogeneity analysis, and clinical implications.
Methodological Advances
Novel techniques for biomarker measurement, sample processing, data analysis, or quality control. Include comparative validation against existing methods.
Short Communications
Preliminary biomarker findings, pilot studies, or rapid dissemination of time-sensitive discoveries. Concise format with focused scope.
Research Focus: We prioritize biomarker studies in the discovery and validation phases. Our scope includes molecular profiling, signature development, and analytical validation. We do not publish clinical diagnostic studies, treatment decision algorithms, or patient management protocols. Your research should advance biomarker science rather than immediate clinical application.
Pre-Submission Checklist
Ensure your biomarker manuscript is submission-ready by verifying these essential components. A complete submission accelerates the review process and demonstrates research quality.
Transparent Peer Review Timeline
We believe in complete transparency throughout the publication process. Here's exactly what happens to your biomarker manuscript from submission to publication, with realistic timeframes based on our actual performance data.
Submission & Initial Screening
Your manuscript undergoes technical checks for completeness, formatting compliance, and plagiarism screening using iThenticate. We verify ethical approvals and data availability statements.
3 business daysEditor Assignment
An associate editor with expertise in your specific biomarker domain (genomics, proteomics, metabolomics, etc.) is assigned to manage the peer review process.
2 business daysPeer Review
Two to three independent reviewers with biomarker research expertise evaluate your methodology, statistical rigor, validation approaches, and scientific contribution. Reviewers assess reproducibility and data quality.
21 days averageEditorial Decision
The editor synthesizes reviewer feedback and makes a decision: Accept, Minor Revisions, Major Revisions, or Reject. You receive detailed comments and specific improvement recommendations.
28 days from submissionRevision & Re-Review
If revisions are requested, you submit an updated manuscript with a point-by-point response to reviewer comments. Revised manuscripts undergo expedited re-review focusing on addressed concerns.
14 days for re-reviewAcceptance & Production
Upon acceptance, your manuscript enters production for copyediting, typesetting, and XML conversion. You review proofs before final publication.
10 days to publicationOnline Publication
Your biomarker research is published online with immediate Open Access. Your work is Your research gains worldwide visibility through indexing in Google Scholar, connecting it with the global scientific community.
Immediate global accessTotal Timeline: From submission to publication, most biomarker manuscripts complete the entire process in approximately 60 days. Fast-track review is available for time-sensitive discoveries or breakthrough findings. Our 68% acceptance rate reflects our commitment to publishing rigorous, high-quality biomarker science while maintaining selective standards.
Why Biomarker Researchers Choose IJPM
We've built our reputation on serving the biomarker research community with integrity, expertise, and transparency. Here's what sets us apart in personalized medicine publishing.
Expert Reviewers
Biomarker specialists with active research programs in genomics, proteomics, and molecular diagnostics
Rigorous Standards
STARD, REMARK, and MIQE guideline compliance for biomarker reporting quality
Global Indexing
Your research gains worldwide visibility through indexing in Google Scholar, connecting it with the global scientific community.
Open Access Impact
Immediate worldwide access removes barriers to biomarker knowledge dissemination
COPE
Committee on Publication Ethics membership ensures ethical publishing practices
APC Waivers
Financial support available for researchers from low-income countries and unfunded studies
Fast Decisions
21-day average review time means your biomarker discoveries reach the community quickly
Author Support
Dedicated editorial team assists with submission, revision, and post-publication promotion
Submission Requirements for Biomarker Studies
Manuscript Structure
Biomarker discovery and validation manuscripts should follow a clear structure that enables reproducibility and critical evaluation:
- Abstract: Structured format with Background, Methods, Results, Conclusions (250 words maximum)
- Introduction: Clinical context, unmet need, and biomarker hypothesis
- Materials & Methods: Detailed sample collection, processing protocols, analytical platforms, and statistical methods including multiple testing corrections
- Results: Biomarker discovery findings, validation cohort results, performance metrics (sensitivity, specificity, AUC, PPV, NPV)
- Discussion: Biological interpretation, comparison with existing biomarkers, limitations, and future validation needs
- Data Availability: Repository links for raw data, processed data, and analysis code
Reporting Guidelines
We require adherence to field-specific reporting standards to ensure transparency and reproducibility:
- STARD: Standards for Reporting Diagnostic Accuracy Studies (for biomarker performance studies)
- REMARK: Reporting Recommendations for Tumor Marker Prognostic Studies (for cancer biomarkers)
- MIQE: Minimum Information for Publication of Quantitative Real-Time PCR Experiments (for gene expression biomarkers)
- STROBE: Strengthening the Reporting of Observational Studies in Epidemiology (for cohort studies)
- ARRIVE: Animal Research: Reporting of In Vivo Experiments (for preclinical biomarker studies)
Statistical Requirements
Biomarker studies must include rigorous statistical validation:
- Sample size justification with power calculations
- Training and independent validation cohorts
- Cross-validation or bootstrap resampling for algorithm development
- Multiple testing correction (Bonferroni, FDR, or permutation-based)
- ROC curve analysis with confidence intervals
- Calibration plots for risk prediction models
Ready to Submit Your Biomarker Research?
Join the growing community of biomarker scientists advancing personalized medicine through rigorous discovery and validation research.
Begin Your SubmissionNeed assistance with your submission? Our editorial team is here to help: [email protected]
